DNA Methylation in Serum of Breast Cancer Patients: An Independent Prognostic Marker

Cancer Research

Volumn 63, Issue 22, 2003, Pages 7641-7645

  Müller, Hannes M ^a   Widschwendter, Andreas ^a   Fiegl, Heidi ^a   Ivarsson, Lennart ^a   Goebel, Georg ^b   Perkmann, Elisabeth ^a   Marth, Christian ^a   Widschwendter, Martin ^a  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^b UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BREAST CANCER; BREAST METASTASIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DNA METHYLATION; FEMALE; GENE IDENTIFICATION; HUMAN; MULTIVARIATE ANALYSIS; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; VALIDATION PROCESS;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DNA METHYLATION; FEMALE; GENES, APC; GENES, TUMOR SUPPRESSOR; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM PROTEINS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 18544406053     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Goldhirsch, A., Glick, J. H., Gelber, R. D., Coates, A. S., and Senn, H. J. Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer. J. Clin. Oncol., 19: 3817-3827, 2001.
2. Early Breast Cancer Trialists' Collaborative Group. Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet, 352: 930-942, 1998.
3. Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet, 351: 1451-1467, 1998.
4. Hayes, D. F., Isaacs, C., and Stearns, V. Prognostic factors in breast cancer: current and new predictors of metastasis. J. Mammary Gland Biol. Neoplasia, 6: 375-392, 2001.
5. Hayes, D. F., Trock, B., and Harris, A. L. Assessing the clinical impact of prognostic factors: when is "statistically significant" clinically useful? Breast Cancer Res. Treat., 52: 305-319, 1998.
6. van't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart. A. A., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., Schreiber, G. J., Kerkhoven, R. M., Roberts, C., Linsley, P. S., Bernards, R., and Friend, S. H. Gene expression profiling predicts clinical outcome of breast cancer. Nature (Lond.), 415: 530-536, 2002.
7. van de Vijver, M. J., He, Y. D., van't Veer, L. J., Dai, H., Hart, A. A., Voskuil, D. W., Schreiber. G. J., Peterse, J. L., Roberts, C., Marton, M. J., Parrish, M., Atsma, D., Witteveen, A., Glas, A., Delahaye, L., van der Velde, T., Bartelink, H., Rodenhuis, S., Rutgers, E. T., Friend, S. H., and Bernards, R. A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med., 347: 1999-2009, 2002.
8. Keyomarsi, K., Tucker, S. L., Buchholz, T. A., Callister, M., Ding, Y., Hortobagyi, G. N., Bedrosian, I., Knickerbocker, C., Toyofuku, W., Lowe, M., Herliczek, T. W., and Bacus, S. S. Cyclin E and survival in patients with breast cancer. N. Engl. J. Med., 347: 1566-1575, 2002.
9. Braun, S., Pantel, K., Muller, P., Janni, W., Hepp, F., Kentenich, C. R., Gastroph, S., Wischnik, A., Dimpfl, T., Kindermann, G., Riethmuller, G., and Schlimok, G. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. N. Engl. J. Med., 342: 525-533, 2000.
10. Jones, P. A., and Baylin, S. B. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet., 3: 415-428, 2002.
11. Widschwendter, M., and Jones, P. A. DNA methylation and breast carcinogenesis. Oncogene, 21: 5462-5482, 2002.
12. Laird, P. W. Early detection: the power and the promise of DNA methylation markers. Nat. Rev. Cancer, 3: 253-266, 2003.
13. Anker, P., Mulcahy, H., Chen, X. Q., and Stroun, M. Detection of circulating tumour DNA in the blood (plasma/serum) of cancer patients. Cancer Metastasis Rev., 18: 65-73, 1999.
14. Silva, J. M., Dominguez, G., Garcia, J. M., Gonzalez, R., Villanueva, M. J., Navarro, F., Provencio, M., San Martin, S., Espana, P., and Bonilla, F. Presence of tumor DNA in plasma of breast cancer patients: clinicopathological correlations. Cancer Res., 59: 3251-3256, 1999.
15. Chen, X., Bonnefoi, H., Diebold-Berger, S., Lyautey, J., Lederrey, C., Faltin-Traub, E., Stroun, M., and Anker, P. Detecting tumor-related alterations in plasma or serum DNA of patients diagnosed with breast cancer. Clin. Cancer Res., 5: 2297-2303. 1999.
16. Shao, Z. M., Wu, J., Shen, Z. Z., and Nguyen, M. p53 mutation in plasma DNA and its prognostic value in breast cancer patients. Clin. Cancer Res., 7: 2222-2227, 2001.
17. Silva, J. M., Garcia, J. M., Dominguez, G., Silva, J., Miralles, C., Cantos, B., Coca, S., Provencio, M., Espana, P., and Bonilla. F. Persistence of tumor DNA in plasma of breast cancer patients after mastectomy. Ann. Surg. Oncol., 9: 71-76, 2002.
18. Leon, S. A., Shapiro, B., Sklaroff, D. M., and Yaros, M. J. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res., 37: 646-650, 1977.
19. Goessl, C., Krause, H., Muller, M., Heicappell, R., Schrader, M., Sachsinger, J., and Miller, K. Fluorescent methylation-specific polymerase chain reaction for DNA-based detection of prostate cancer in bodily fluids. Cancer Res., 60: 5941-5945, 2000.
20. Sanchez-Cespedes, M., Esteller, M., Wu, L., Nawroz-Danish, H., Yoo, G. H., Koch, W. M., Jen, J., Herman, J. G., and Sidransky, D. Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. Cancer Res., 60: 892-895, 2000.
21. Wong, I. H., Lo, Y. M., Zhang, J., Liew, C. T., Ng, M. H., Wong, N., Lai, P. B., Lau, W. Y., Hjelm, N. M., and Johnson, P. J. Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients. Cancer Res., 59: 71-73, 1999.
22. Silva, J. M., Dominguez, G., Villanueva, M. J., Gonzalez, R., Garcia, J. M., Corbacho, C., Provencio, M., Espana, P., and Bonilla, F. Aberrant DNA methylation of the p16INK4a gene in plasma DNA of breast cancer patients. Br. J. Cancer, 80: 1262-1264, 1999.
23. Kawakami, K., Brabender, J., Lord, R. V., Groshen, S., Greenwald, B. D., Krasna, M. J., Yin, J., Fleisher, A. S., Abraham, J. M., Beer, D. G., Sidransky, D., Huss, H. T., DeMeester, T. R., Eads, C., Laird, P. W., Ilson, D. H., Kelsen, D. P., Harpole, D., Moore, M. B., Danenberg, K. D., Danenberg, P. V., and Meltzer, S. J. Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma. J. Natl. Cancer Inst., 92: 1805-1811, 2000.
24. Lecomte, T., Berger, A., Zinzindohoue, F., Micard, S., Landi, B., Blons, H., Beaune, P., Cugnenc, P. H., and Laurent-Puig, P. Detection of free-circulating tumor-associated DNA in plasma of colorectal cancer patients and its association with prognosis. Int. J. Cancer, 100: 542-548, 2002.
25. Eads, C. A., Danenberg, K. D., Kawakami, K., Saltz, L. B., Blake, C., Shibata, D., Danenberg, P. V., and Laird, P. W. MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res., 28: E32, 2000.
26. Eads, C. A., Lord, R. V., Wickramasinghe, K., Long, T. I., Kurumboor, S. K., Bernstein, L., Peters, J. H., DeMeester, S. R., DeMeester, T. R., Skinner, K. A., and Laird, P. W. Epigenetic patterns in the progression of esophageal adenocarcinoma. Cancer Res., 61: 3410-3418, 2001.
27. Klein, C. A., Blankenstein, T. J., Schmidt-Kittler, O., Petronio, M., Polzer, B., Stoecklein, N. H., and Riethmuller, G. Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer. Lancet, 360: 683-689, 2002.
28. Dammann, R., Yang, G., and Pfeifer, G. P. Hypermethylation of the cpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers. Cancer Res., 61: 3105-3109, 2001.
29. Virmani, A. K., Rathi, A., Sathyanarayana, U. G., Padar, A., Huang, C. X., Cunnigham, H. T., Farinas, A. J., Milchgrub, S., Euhus, D. M., Gilcrease, M., Herman, J., Minna, J. D., and Gazdar, A. F. Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas. Clin. Cancer Res., 7: 1998-2004, 2001.
30. Fearnhead, N. S., Britton, M. P., and Bodmer, W. F. The ABC of APC. Hum. Mol. Genet., 10: 721-733, 2001.
31. Dammann, R., Schagdarsurengin, U., Strunnikova, M., Rastetter, M., Seidel, C., Liu, L., Tommasi, S., and Pfeifer, G. P. Epigenetic inactivation of the Ras-association domain family 1 (RASSF1A) gene and its function in human carcinogenesis. Histol. Histopathol., 18: 665-677, 2003.
32. Garcia-Olmo, D., and Garcia-Olmo, D. C. Functionality of circulating DNA: the hypothesis of genometastasis. Ann. N. Y. Acad. Sci., 945: 265-275, 2001.